Market Insights
Opportunity knocks for those with trading in their DNA.
Curiosity creates opportunity. Insights create strategy. Born traders create their destiny.
Rates, Geopolitics Cast Gloom Before Earnings: Market Trends This Week
Downloads are available here. TradeStation’s ideas on TradingView are available here. Register for Market Trends here. Sizing Up the S&P 500 S&P 500 has retraced about half its move since breaking 2022 high S&P 500 testing bullish gap from...
Ethereum Breaks Out to New Highs, Leaving Rivals Like Bitcoin in the Dust
Ethereum's hitting new highs today, becoming the first major cryptocurrency to break out after a two-week pullback in the space. ETHUSD touched $2,683 today, $37 above its peak on April 22. Meanwhile Bitcoin (BTCUSD) remained about 15 percent below its record high in...
The Fed Meets This Week as Business Roars Back from the Coronavirus Pandemic
The economy is roaring back to life, just in time for the Federal Reserve to keep interest rates low. No major change in policy is expected from the central bank on Wednesday. Fed Chairman Jerome Powell has repeatedly said inflation needs to go solidly above 2 percent...
Chart Study: Do You Know This Chipmaker Getting Close to Record Highs?
Micron Technology (MU) has stalled after a big rally. Is it time to buy the dip? The first pattern on the memory-chip maker's chart is the oversold condition on stochastics. Given its current uptrend, strong fundamentals and positive macro backdrop (GDP +6%), that...
Nio Could Be Attempting a Breakout Before Earnings Next Week: Chart Study
Nio was one of the top stocks in 2020, making even Tesla look like a savings bond. It’s pulled back hard and is now stabilizing with earnings around the corner. The biggest pattern is the 200-day moving average. Interestingly, TSLA bounced at this exact same line...
You Can Prepare for Earnings Season With These Powerful Tools on TradeStation
Earnings are expected to grow the most in a decade as Wall Street rebounds from last year's pandemic. Are you ready for the flood of quarterly results, which next week include major stocks like Apple and Tesla? More than one-third of the S&P 500 is scheduled to...
Four Key Options Strategies to Know With the Biggest Week of Earnings Season About to Begin
Next week is the biggest week of earnings season. More than one-third of the S&P 500's members announce results, including the biggest companies like Apple. This blog post will focus on options strategies that can help stock investors during earnings season. It...
Technology & Communication
Like Cryptocurrencies? Check out the Price Action in this Bitcoin Mining Stock
Bitcoin miner Riot Blockchain has been skidding lower since February, but now it could be ready to move again. The main feature on its chart is its jump above the 50-day moving average on July 26. It’s formed a tight consolidation pattern above the line since. The...
IPOs Have Another Strong Month in June
Initial public offerings (IPOs) keep coming at their quickest pace in three years. Some $4.5 billion of stock in new companies came to market last month, according to data from ClickIPO. It was the busiest June since 2015. Click here for more stories about IPOs. The...
Some Interesting Chart Patterns as Q3 Gets Started
Stocks began July on a positive note yesterday, led by technology. Several big names are also showing some patterns that could be interesting -- especially if investors are seeking opportunities at the start of a new quarter. As usual, we started by firing up...
In search of millennial melt-ups: Sprint
Last week we reviewed a couple of "millennial melt-up" stocks. We're continuing today with a name many younger adults likely know well: Sprint (S). Remember, the goal is to find stocks trading for less than $10. They need to be easily recognizable for investors who...
Guess who’s raiding the medicine chest
News reports have seen it coming for months, but now it's official: Amazon.com (AMZN) is attacking drug distributors. AMZN announced the purchase of closely held PillPack. The smaller company caters to patients who routinely take large numbers of medicines, like for...